Ayala Pharmaceuticals, Inc. (ADXS)
OTCMKTS · Delayed Price · Currency is USD
0.5115
+0.0160 (3.23%)
At close: Jan 23, 2026
Ayala Pharmaceuticals Market Cap
Ayala Pharmaceuticals has a market cap or net worth of $30.33 million as of January 23, 2026. Its market cap has increased by 34.12% in one year.
Market Cap
30.33M
Enterprise Value
n/a
Revenue
13.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.51
Market Cap Chart
Since October 19, 2023, Ayala Pharmaceuticals's market cap has increased from 9.68M to 30.33M, an increase of 213.48%. That is a compound annual growth rate of 65.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 29.39M | 1,369.21% |
| Dec 31, 2025 | 2.00M | 50.26% |
| Dec 31, 2024 | 1.33M | -83.23% |
| Dec 29, 2023 | 7.94M | -18.00% |
| Oct 19, 2023 | 9.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 43.94M |
| Oncotelic Therapeutics | 39.59M |
| LakeShore Biopharma | 34.82M |
| ZIVO Bioscience | 33.07M |
| Harvard Apparatus Regenerative Technology | 25.49M |
| EOM Pharmaceuticals Holdings | 24.54M |
| Provectus Biopharmaceuticals | 22.70M |